Search details
1.
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.
Immunity
; 44(2): 343-54, 2016 Feb 16.
Article
in English
| MEDLINE | ID: mdl-26872698
2.
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.
Immunity
; 45(4): 931-943, 2016 10 18.
Article
in English
| MEDLINE | ID: mdl-27717798
3.
Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas.
Oncoimmunology
; 8(11): e1660121, 2019.
Article
in English
| MEDLINE | ID: mdl-31646109
4.
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Science
; 359(6371): 91-97, 2018 Jan 05.
Article
in English
| MEDLINE | ID: mdl-29097494
5.
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.
Oncoimmunology
; 6(1): e1137418, 2017.
Article
in English
| MEDLINE | ID: mdl-28197361
6.
Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate.
Oncoimmunology
; 5(6): e1160193, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-27471635
7.
The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.
Autophagy
; 12(5): 864-75, 2016 05 03.
Article
in English
| MEDLINE | ID: mdl-26979828
8.
The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ.
Oncoimmunology
; 5(10): e1218106, 2016.
Article
in English
| MEDLINE | ID: mdl-27853639
9.
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.
J Clin Invest
; 126(3): 921-37, 2016 Mar 01.
Article
in English
| MEDLINE | ID: mdl-26854930
10.
Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study.
Arthritis Res Ther
; 17: 241, 2015 Sep 04.
Article
in English
| MEDLINE | ID: mdl-26336930
11.
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.
Autophagy
; 11(10): 1878-90, 2015.
Article
in English
| MEDLINE | ID: mdl-26506894
12.
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.
Sci Transl Med
; 7(283): 283ra55, 2015 Apr 15.
Article
in English
| MEDLINE | ID: mdl-25877893
13.
Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy.
Oncotarget
; 6(25): 20840-50, 2015 Aug 28.
Article
in English
| MEDLINE | ID: mdl-26369701
14.
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.
Science
; 350(6264): 1079-84, 2015 Nov 27.
Article
in English
| MEDLINE | ID: mdl-26541610
15.
Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering.
Cancer Res
; 74(1): 68-80, 2014 Jan 01.
Article
in English
| MEDLINE | ID: mdl-24197135
16.
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.
Nat Med
; 20(11): 1301-9, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25344738
17.
Potent immunomodulatory effects of the trifunctional antibody catumaxomab.
Cancer Res
; 73(15): 4663-73, 2013 Aug 01.
Article
in English
| MEDLINE | ID: mdl-23737485
18.
Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR+ NK cell levels correlate with disease outcome.
Oncoimmunology
; 2(2): e23080, 2013 Feb 01.
Article
in English
| MEDLINE | ID: mdl-23525357
19.
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.
Cancer Res
; 73(12): 3499-510, 2013 Jun 15.
Article
in English
| MEDLINE | ID: mdl-23592754
20.
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.
Sci Transl Med
; 5(195): 195ra96, 2013 Jul 24.
Article
in English
| MEDLINE | ID: mdl-23884468